- The risk of refusing a newborn’s vitamin K shotHealth care workers on strike at Ebola treatment center, how to tackle the U.S. alcohol epidemic, and more Morning Rounds newsSTAT · 12d ago↗ source
- STAT+: Pharmalittle: We’re reading about a battle between Lilly and Teva, psychedelic drugs, and moreA U.S. appeals court revived a Teva Pharmaceuticals lawsuit accusing Eli Lilly of breaching an agreement allowing Teva to market a generic version of ForteoSTAT · 12d ago↗ source
- STAT+: Biogen Alzheimer’s drug slowed decline at rates on par with approved therapies, study showsAn experimental Alzheimer's drug from Biogen, one with a novel approach, slowed decline at comparable rates as approved drugs in a mid-stage study.